Policy

Reviewing Race and Kidney Disease in the NKF-ASN Task Force Report

September 28th 2021, 10:15pm

Podcast

On this episode of Managed Care Cast, we speak with Susan Quaggin, MD, FASN, a nephrologist and the chief of nephrology/hypertension and director of the Feinberg Cardiovascular and Renal Research Institute at Northwestern University, as well as current president of the American Society of Nephrology (ASN). She discusses the recommendations of the National Kidney Foundation (NKF) and ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Diseases and what comes next for laboratories, clinicians, and patients.

Medicaid Expansion Linked With Reduction in Uninsurance and Improved Blood Pressure, Glucose Control Measures

September 27th 2021, 3:00pm

Article

Results of a representative study of patients at federally qualified health centers found Medicaid expansion was associated with reduced rates of uninsurance, improved blood pressure and diabetes control measures, and progress in closing racial care disparities over 5 years.

AJMC® in the Press, September 24, 2021

September 24th 2021, 2:47pm

Article

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Remove Race From Equation Used to Assess Kidney Function, Researchers Say

September 23rd 2021, 4:00pm

Article

Long-awaited reports released Thursday call for eliminating race in estimated glomerular filtration rate equations and point to alternatives in an effort to eliminate disparities in chronic kidney disease.

What We’re Reading: US Set to Increase Vaccine Donation; Home Births Increase; Aduhelm Sales Slower Than Expected

September 22nd 2021, 3:31pm

Article

President Joe Biden reportedly will increase global COVID-19 vaccine donations; the pandemic may have led to an increase in home births; use of Biogen’s Adulhelm, an Alzheimer disease drug, does not hit initial projections.

A Timeline of COVID-19 Vaccine Developments for the Second Half of 2021

September 21st 2021, 6:15pm

Article

As the second half of 2021 ended and Americans hoped for a summer of freedom from social distancing, a new threat was emerging due to lagging vaccination rates despite the widespread availability of 3 vaccines for COVID-19.

PCOS Estimated to Cost $8 Billion in Immediate, Long-term Health Issues

September 21st 2021, 1:00pm

Article

An updated report shows that the long-term cost of treating the health effects of polycystic ovary syndrome (PCOS)—$4.3 billion—is even higher than $3.7 billion it takes to diagnose and treat immediate issues that present for women who are of reproductive age.

What We’re Reading: Pfizer Underscores Vaccine Safety; COVID-19 Vaccine Efficacy Updated; Democrats Push Health Care Reforms

September 20th 2021, 1:46pm

Article

Pfizer says a newly formulated dose of its vaccine is safe and effective in children; CDC data underscore the efficacy of the 3 COVID-19 vaccines; Biden aims to reform health care with trillion-dollar package.

Contributor: The Price of Mental Wellness

September 19th 2021, 1:00pm

Article

Considering the personal, societal, and economic toll of treatment-resistant depression, we must make it easier to access medicines and care that provide value, both for the patient and for the health care system.

States Late to Adopt PrEP Risk Falling Further Behind

September 18th 2021, 3:00pm

Article

A new analysis of 2014-2018 data among all states plus Washington, DC, for those who have either indications for preexposure prophylaxis (PrEP) or current prescriptions for the preventive treatment, shows a widening gap in PrEP uptake, with states considered early adopters pulling ahead of those considered late adopters.